Skip to main content
Erschienen in: International Journal of Hematology 1/2014

01.07.2014 | Original Article

Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu–Yamaguchi Children’s Cancer Study Group

verfasst von: Hiroshi Moritake, Sachiyo Kamimura, Hiroyuki Nunoi, Hideki Nakayama, Aiko Suminoe, Hiroko Inada, Jiro Inagaki, Fumio Yanai, Yasuhiro Okamoto, Yuichi Shinkoda, Maiko Shimomura, Nobuyoshi Itonaga, Noriko Hotta, Yasufumi Hidaka, Osamu Ohara, Masakatsu Yanagimachi, Noriko Nakajima, Jun Okamura, Yoshifumi Kawano

Erschienen in: International Journal of Hematology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

This present study sought to analyze acute lymphoblastic leukemia (ALL) patients with hemophagocytic lymphohistiocytosis (HLH) registered in Kyushu–Yamaguchi Children’s Cancer Study Group studies conducted between 1996 and 2007. Four of 357 patients, including two of 318 patients with B cell precursor acute lymphoblastic leukemia (BCP-ALL) and two of 39 of those with T cell acute lymphoblastic leukemia (T-ALL), were identified. HLH was observed more frequently in the T-ALL patients than in the BCP-ALL patients (P = 0.061). The mean age of 13.0 years at the diagnosis of leukemia in the HLH + ALL group was significantly higher than the 6.05 years observed in the remaining ALL groups (P = 0.001). A female predisposition was noted, as all four patients were female (P = 0.043). In two of four patients, the leukemic cells exhibited deletions on the long arm of chromosome 6 (P = 0.003). Three patients suffered from HLH during maintenance therapy. Parvovirus B19 infection and cytomegalovirus reactivation were identified as causes of HLH in one and two patients, respectively. All four patients are currently in complete remission, although one developed relapse of leukemia after receiving maintenance therapy. Based on the genetic analyses, non-synonymous single nucleotide polymorphisms (SNPs) in UNC13D, syntaxin 11, and STXBP2 were identified in all patients. Clinicians should therefore be aware of the risk of HLH during maintenance therapy, especially in older T-ALL patients with SNPs in familial HLH causative genes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005;82–88. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005;82–88.
2.
Zurück zum Zitat Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65.PubMedCrossRef Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65.PubMedCrossRef
3.
Zurück zum Zitat Lackner H, Urban C, Sovinz P, Benesch M, Moser A, Schwinger W. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica. 2008;93:291–4.PubMedCrossRef Lackner H, Urban C, Sovinz P, Benesch M, Moser A, Schwinger W. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica. 2008;93:291–4.PubMedCrossRef
4.
Zurück zum Zitat Trebo MM, Attarbaschi A, Mann G, Minkov M, Kornmüller R, Gadner H. Histiocytosis following T-acute lymphoblastic leukemia: a BFM study. Leuk Lymphoma. 2005;46:1735–41.PubMedCrossRef Trebo MM, Attarbaschi A, Mann G, Minkov M, Kornmüller R, Gadner H. Histiocytosis following T-acute lymphoblastic leukemia: a BFM study. Leuk Lymphoma. 2005;46:1735–41.PubMedCrossRef
5.
Zurück zum Zitat Nagatoshi Y, Matsuzaki A, Suminoe A, Inada H, Ueda K, Kawakami K, et al. Randomized trial to compare LSA2L2 type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;55:239–47.PubMedCrossRef Nagatoshi Y, Matsuzaki A, Suminoe A, Inada H, Ueda K, Kawakami K, et al. Randomized trial to compare LSA2L2 type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;55:239–47.PubMedCrossRef
6.
Zurück zum Zitat Henter JI, Horne A, Aricò M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.PubMedCrossRef Henter JI, Horne A, Aricò M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.PubMedCrossRef
7.
Zurück zum Zitat Katano H, Kano M, Nakamura T, Kanno T, Asanuma H, Sata T. A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses. J Med Virol. 2011;83:322–30.PubMedCrossRef Katano H, Kano M, Nakamura T, Kanno T, Asanuma H, Sata T. A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses. J Med Virol. 2011;83:322–30.PubMedCrossRef
8.
Zurück zum Zitat Yanagimachi M, Goto H, Miyamae T, Kadota K, Imagawa T, Mori M, et al. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. J Clin Immunol. 2011;31:946–51.PubMedCrossRef Yanagimachi M, Goto H, Miyamae T, Kadota K, Imagawa T, Mori M, et al. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. J Clin Immunol. 2011;31:946–51.PubMedCrossRef
9.
Zurück zum Zitat Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM study group. J Clin Oncol. 2009;27:377–84.PubMedCrossRef Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM study group. J Clin Oncol. 2009;27:377–84.PubMedCrossRef
10.
Zurück zum Zitat zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827–834. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827–834.
11.
Zurück zum Zitat Berthou C, Marolleau JP, Lafaurie C, Soulié A, Dal Cortivo L, Bourge JF, et al. Granzyme B and perforin lytic proteins are expressed in CD34 + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood. 1995;86:3500–3506. Berthou C, Marolleau JP, Lafaurie C, Soulié A, Dal Cortivo L, Bourge JF, et al. Granzyme B and perforin lytic proteins are expressed in CD34 + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood. 1995;86:3500–3506.
12.
Zurück zum Zitat Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T, et al. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 2009;183:1838–45.PubMedCrossRef Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T, et al. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 2009;183:1838–45.PubMedCrossRef
13.
Zurück zum Zitat Bruno AP, Lautier D, d’Orgeix AT, Laurent G, Quillet-Mary A. Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood. 2000;96:1914–20.PubMed Bruno AP, Lautier D, d’Orgeix AT, Laurent G, Quillet-Mary A. Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood. 2000;96:1914–20.PubMed
14.
Zurück zum Zitat Jahrsdörfer B, Blackwell SE, Wooldridge JE, Huang J, Andreski MW, Jacobus LS, et al. B-chronic lymphocytic leukemia cells and other B cell can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood. 2006;108:2712–9.PubMedCentralPubMedCrossRef Jahrsdörfer B, Blackwell SE, Wooldridge JE, Huang J, Andreski MW, Jacobus LS, et al. B-chronic lymphocytic leukemia cells and other B cell can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood. 2006;108:2712–9.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Rouphael NG, Talati NJ, Vaughan C, Conningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814–22.PubMedCrossRef Rouphael NG, Talati NJ, Vaughan C, Conningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814–22.PubMedCrossRef
16.
Zurück zum Zitat Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995;86:4706–7.PubMed Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995;86:4706–7.PubMed
17.
Zurück zum Zitat Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Stills disease. Clin Exp Rheumatol. 2005;23:100–2.PubMed Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Stills disease. Clin Exp Rheumatol. 2005;23:100–2.PubMed
18.
Zurück zum Zitat Oloomi Z, Moayeri H. Cytomegalovirus infection-associated hemophagocytic syndrome. Arch Iran Med. 2006;9:284–7.PubMed Oloomi Z, Moayeri H. Cytomegalovirus infection-associated hemophagocytic syndrome. Arch Iran Med. 2006;9:284–7.PubMed
19.
Zurück zum Zitat Hardikar W, Pang K, Al-Hebbi H, Curtis N, Couper R. Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatric orthotopic liver transplantation. J Pediatr Child Health. 2006;42:389–91.CrossRef Hardikar W, Pang K, Al-Hebbi H, Curtis N, Couper R. Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatric orthotopic liver transplantation. J Pediatr Child Health. 2006;42:389–91.CrossRef
20.
Zurück zum Zitat Knorr B, Kessler U, Pöschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in apreterm infant. Scand J Infect Dis. 2007;39:173–6.PubMedCrossRef Knorr B, Kessler U, Pöschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in apreterm infant. Scand J Infect Dis. 2007;39:173–6.PubMedCrossRef
21.
Zurück zum Zitat Te Poele EM, de Bont ES, Marike Boezen H, Revesz T, Bökkerink JP, Beishuizen A, et al. Dexamethasone in the maintenance phase of acute lymphoblastic leukemia treatment: Is the risk of lethal infections too high? Eur J Cancer. 2007;43:2532–2536. Te Poele EM, de Bont ES, Marike Boezen H, Revesz T, Bökkerink JP, Beishuizen A, et al. Dexamethasone in the maintenance phase of acute lymphoblastic leukemia treatment: Is the risk of lethal infections too high? Eur J Cancer. 2007;43:2532–2536.
22.
Zurück zum Zitat Moritake H, Kamimura S, Kojima H, Shimonodan H, Harada M, Sugimoto T, et al. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:329–31.PubMedCrossRef Moritake H, Kamimura S, Kojima H, Shimonodan H, Harada M, Sugimoto T, et al. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:329–31.PubMedCrossRef
23.
Zurück zum Zitat Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentation in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016–24.PubMedCrossRef Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentation in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016–24.PubMedCrossRef
24.
Zurück zum Zitat Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769–74.PubMedCrossRef Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769–74.PubMedCrossRef
25.
Zurück zum Zitat Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–73.PubMedCrossRef Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–73.PubMedCrossRef
26.
Zurück zum Zitat Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rhuem. 2008;58:2892–6.CrossRef Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rhuem. 2008;58:2892–6.CrossRef
27.
Zurück zum Zitat Yamamoto K, Ishii E, Horiuchi H, Ueda I, Ohga S, Nishi M, et al. Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J Hum Genet. 2005;50:600–3.PubMedCrossRef Yamamoto K, Ishii E, Horiuchi H, Ueda I, Ohga S, Nishi M, et al. Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J Hum Genet. 2005;50:600–3.PubMedCrossRef
28.
Zurück zum Zitat zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482–492. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482–492.
29.
Zurück zum Zitat Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc-18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765–73.PubMedCentralPubMedCrossRef Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc-18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765–73.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. J Clin Oncol. 2010;28:e661–2.PubMedCrossRef Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. J Clin Oncol. 2010;28:e661–2.PubMedCrossRef
Metadaten
Titel
Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu–Yamaguchi Children’s Cancer Study Group
verfasst von
Hiroshi Moritake
Sachiyo Kamimura
Hiroyuki Nunoi
Hideki Nakayama
Aiko Suminoe
Hiroko Inada
Jiro Inagaki
Fumio Yanai
Yasuhiro Okamoto
Yuichi Shinkoda
Maiko Shimomura
Nobuyoshi Itonaga
Noriko Hotta
Yasufumi Hidaka
Osamu Ohara
Masakatsu Yanagimachi
Noriko Nakajima
Jun Okamura
Yoshifumi Kawano
Publikationsdatum
01.07.2014
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 1/2014
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1591-1

Weitere Artikel der Ausgabe 1/2014

International Journal of Hematology 1/2014 Zur Ausgabe

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.